Interrelationships Among Thiazide Diuretics and Calcium, Magnesium, Sodium, and Potassium Balance in Normal and Hypertensive Man JAY
C
thiaside
FIRONIC
to
diuretic
depletion
nesium
M. SULLIVAN.
and
of
therapy
potassium
retention
and
of calcium
acid in man.’-6 It has intravenous infusion
potassium loss in man,7 use of oral magnesium
as
potassium-sparing
a
on chronic
urinary
with
a history
of
ever,
the
of magnesium
on
calcium
effect
thiazide-induced
and
nesium, and was the main
that re-
hypertensive
take
patients
place if
or the
the
Departments
Brigham Boston,
Hospital, Mass., and
and
blood mag-
balance in man. It of this study to de-
College
of
Medicine,
in part by Grant 8-MO1-FR-31-06 eral Clinical Research Centers Division of Research Resources, tutes of Health, and by grants A. Hartford Foundation and poration. through 530
Computation USPHS Grant
services HL-09495.
Peter
Medical of Tenn. from
Bent
School, Tennessee Supported the
Gen-
Program of the National Instifrom the John the Schering Corwere
normal
in
the
changes
two
and
studied
differences which are
by
potastherapy de-
in blood known to
groups in
to
were
cation
replacement
ac-
balance enhanced
effect
of
the
thia-
zides.
uric
diuretics,
Harvard the University Memphis,
for
Both were
the
magnesium
Material
replacement
Medicine,
replace-
need
how-
potassium,
of
diuretics.
antihypertensive
provided
and
Methods
Twenty-five 12 normal
studies
were
subjects
and
essential hypertension.
out in
carried
13 subjects Ten
with
of the normal
subjects were males and two, females. Their ages ranged from 21 through 25 years.
The
hypertensive
older, with an and
From
the
during
whether response
companied
in
magnesium
patients
termine pressure
pa-
thiaaide
calcium purpose
thiazide
not
formation,8
sodium,
with
has
suppleknown to
oral
eliminate
supplementation
for
calcium
among
pressure,
iuin
has not been studied. study concerns the interre-
acid retention The present lationships
uric
whether would
therapy
levels
stone
termine inent
but the posupplement
Daily dietary oxide are
raise
leads mag-
measure diuretic
yet been explored. ments of magnesium
and
been reported of magnesium
duces tential tients
M.D.. ROBERT G. DLUHY. M.D., WARREN E. C. WACKER. M.D.. HAROLD S. SOLOMON. M.D., GORDON H. WILLIAMS. M.D.. and JOSEPH K. SAMAHA. M.D. Boston Mass., and Memphis, Tenn.
a mean
males
and
taking,
age
were
shown
metabolic tients
ing
females.
examination,
testing,
the renal,
diseases. had
The
95 Journal
and
routine subjects
evidence or
Clinical
pressures mm Hg
of
other
hypertensive
blood 120 of
were history
and
hepatie, The
diastolic
between
On
normal
to be free of any
cardiovascular,
were
of 42 years. Eight
five were
physical
laboratory
subjects
of 29 to 65 years
age range
pa-
rangon at
Pharmacology
THIAZIDES
least
three
separate
tions
while
not
outpatient
receiving
determina-
patients
forms
had
of hypertension
taking,
physical
quence
intravenous
urinary or
of vanillylmandelic
metanephrines,
of
heart
function
failure
Research
Brigham ad
clearance. admitted to the of
1-lospital
rates were
measured
the
position
supine
upright All
stant, mEq
isocaloric sodium,
mg ml
subjects
study who
intake
placed
on diets
a period of 12 urine collections measurement acid, total
chloride,
C02,
calcium,
acid, protein, and of each four-day renin
activity
trations
and
were and
position tion,
and
subjects
a 10
mEq
per
after
measurement sodium, potassium, phosphorous,
angiotensin four
the
hours
of
glucose
were
measured.
rates
were
Noveniber-December
day.
uric
ambulaelecon
mg
for a period measurements of the
The of been
of 12th
magnesium 100 mg was
established
excretion
that of
mag-
during
the
administration
of
diuretic
was
approximately
100
B. Two
subjects
mg/24
hr.
Group identical
manner
magnesium study
period
same
changes
sence
of
C.
to determine
of
with
the
normal
and
ab-
effect
of
in
re-
oxide
be-
the
magnesium
during the
the
subjects
magnesium during
period assess
third
whether
agents
administered
chlormethiazide to
of
the
magnesium. Four
order,
study
in
take place in the
pharmacologic
versed
studied addition
during
would
added
received ing
were
without
supplement
second plus
the
third
order
of
tn-
period, adminis-
tration. 13
The
Group studied
hypertensive
patients
1).
of
Seven
the
patients
at the end of a four-day
equilibration in On trichlormcthiazide
plus
were
as follows:
100
another
Aldos-
100
in addi-
the hospital, then for four days
measurements
mg
magnesium
four-day were
period repeated
were
period
end of which measurements were They were themi placed on thiazide
supine
measured
on
mouth
morning
urinary
days,
repeated.
placed by
the
it had
average
studied
the end plasma
and
terone
the same
of
II eoncenin
trocardiograms secretion
uric
ereatinine, and were obtained
magnesium. At study period,
blood
for
potassium,
measured
fasting
day
maintained
after
Group
Twenty-four-hour made daily for
magnesium, Blood samples
then daily
on
four
were
nesium
entire
three
were
for
their
2000
for
days. were
every other day hematocrit, creatinine,
100 100
and
repeated
an
contained potassium,
of
on
a period
thiazide
in the a con-
for
of sodium,
calcium, volume.
in
end
to triehlormethiazide days, and the ba.seline
the
on
calcium,
daily
except
diet. All
sodium
mg
were oxide
placed for
the
selected
measured
placed
diet which 100 mEq
period, were
5 minutes
At
Cliniwas
The 12 as fol-
were
measurements
subjects
tion four
subjects
day of hospitalization. supplementation dose
pulse
2 minutes
were
100
fluid
after
was
days.
baseline
were
Bent
and
Weight
magnesium, total
Peter
pressure and
Position.
daily.
the
Six
or by
for study. Activity
Blood
lihitum.
impaired
urinalysis
Center
of
of equilibration. were then treated
trichlormethiazide
eight
The
evidence
or
by routine
endogenous ereatinine The patients were cal
had
A.
b.i.d.
magnesium
None
subjects
congestive
renal
acid,
determination.
hypertensive
of the
17-hydroxysteroids,
17-ketosteroids
the
se-
24-hour
the above measat the end of a
lows: 4 mg
rapid
pyelogram,
period subiects
Group
on history
examination,
values for all were obtained
four-day normal
of secondary
revealed
excretion
total
agents were weeks prior to of the hyper-
evidence
MAGNESIUM
Control urements
antihypertensive
agents. All antihypertensive discontinued at least three admission for study. None tensive
AND
oxide
repeated. diuretic daily
after for
of
placed at the
the
for
which third
time. 1978
531
SULLIVAN,
Group E. Three patients at the end of the four-day and
then
daily
started
for
ceiving
an
on
were control
100
eight-day
diuretic
mg
studied period
magnesium
period
without
mg
three sodium
of magnesium system when
oxide
Magnesium renin
activity
renin
activity
tration described
and
was
method
renin
EDTA
tion at renin
25#{176}Cfor
tration.
Blood and by
II
of
ranged
from
to
different
concentrations. computer
analysis nificance
of data. using
variance
with
formed
between
analysis
within
for
more or
cant.’3 This Studies 532
less
per
by
factors factors,
regimens.
was
test
detailed
analysis.
were
considered
sigof per-
and
one
testing
for
a was
Newman-
P
was
Committee
approved
values
of
by the the
Peter
diuresis
(10.2
five
diastolic
below
diastolic
P
4
-
I
U) 0)
40
.-
N.1
.121 N.I U)
0
NJ. C’S
0 I_
U)
4.1
40
.V
c
0
NJ. N.
.V
0
04
d N.
11.1
o
0-5
01
+
V
i.--- 4040 N 4
I.-
V
(‘I CN
N
V ..-N
2040
4) V
V
N
#{149}.C I-
4 .40
.-
‘0 N 0 Z
4’
N N 4’
N 0
4’
CN
N 4’
N
0-
-N
40
1978
NJ N.
I
05(5)
Z
#{149}
II C
40
20
+
VI 4)
4)40
V
V N 4040
>..--
VI
I I I I 10
In
Q)
N
>
N
4) 0. >5-.
Iii COO
0LI
LI
E 0
E 0
I1.
S
N
4’
N 4’
4411 0. >5
0
November-December
U; 0’
Cm---E
0. +4
NJ
N C
50
0. +1
U)]
N.
0
U)
+4
P.
+ 4240
#{149}V
OJ
U;
I
40
40
4040
P1
NJ
05
40
0.
+4
j
NJ
U)
0
40.
.
-V
0)
o. +4
U
0 0)
.V
.-
o. +11
o
0
.-.
4’
4’
N
N 4’
II N 4’
I
N
N
I
4.1 4
4.1
I
LI
533
SULLIVAN,
DL UHF,
0
0 0’
+
WACKER,
N
C 50
SO 0
d
d
;
5444 4-C #{149}0
+4
*4
+4
40
50 N
(55
o
c-i
*4
AL.
*4
-H
*4
C’,
C
: :
0 N
N N
(54 C
0) 0
0
s:;
c
C ‘0
C
c’
ET
4--
0
10
C, V
: :1:1:1
#{149}4 CO
C
4, .0
1 1
0. 4,
50
a,
50-tn
0
0
.40
59
4-.
‘0
a,
Ii)
0
0
0..-
0.-
-
0. 4-I C 0
I
0
c
‘9
40
0 N
4) 50
La
C
N 0
‘9
40 N
44
.0
0 I-
!: : : !
44
N
#{128} - ii
0
15
C
-C
-
--N
N
C
,-
C-
N
C)
CO
;i
]
:J
‘9
40 N
* 40
N C
0 5
19
5)
0) C5
o
o
0
0
Sn
N
N
50
C)
N
N
N1
1
5)
0
-
.
N
Sn
2
5000
115
0
0
0
+
;
i
Ei 50 C
5444 4-
#{149}0 N
“.4
S0
‘0
0
Z 0
4, #{149}0
50
N
.-
O
0
In
0
Sn
0
N
Lb
40
0
I
N
00 V 0
OSJ
444
0 +4 4-. U U
I-
w
44
*5
C’S Sn
(55 0)50
4
+4
4-I
+4
*4
0.
40 ONION
>5 #{149}0
0 In
0 CI-
0 I0 4
44 .40 V U 44
534
t+0 tU
00-0-. 0.1.1
.
.
0.05
a
. 0.0W .
III fl0
LU 0
-.
N
LU
U0 .
N 05
.
‘rue
4
Journal
of
Clinical
Pharmacology
THIAZIDES
AND
MAGNESIUM
t’.*
11
ONNO1000)N.O*0 41 +4 0’94)OiIn4005a)
NJ
C-NSONCOO 44
+4
+4
+4
44
-54
+4
+4
+4
NC0CIO40CO.IOC
SONN.CC4
+4
+4
I
+4
+4
‘ N.
C-
NJCONJ0)NNJ0).d
:
:
o
0
40
Ii)
0)
Ii)
CO
40
4)
0
CQ400)0)44040
C
C
N.
C
115
C-
N
N
40
C
-
40
C-
CCI
0) N
CO 115
CO 0
N CCI
.
N
CD 40
CD N
C-0)Nc-ia)t0’0NC
NNN0)OONNO
+ IC V
:
N
:
OCN40CNOU)N
0NCLa2d,
OIOCCCJCCOP-.O
C-0)CNN4)40
0 NN.CCiNQ.0)N050
a)
:
:
0N0)CO4)0)CO
ONSONU).-
10
N.
N
N
CO
N
0)
N
N
40
N
NCCN.ONNNC.-
0) CO
CCI
0) N
Cfl IL)
50 N
) 05
#{149}
3 CL)
CO N
N 115
N 0)
N III
+4 *4 ‘9N).N.0CN0 N
0) N
4) C
0NCONO)0N40.-N
OCNNI0000)0)N
40
N
C4QO)0da,3
+4
N
CO
C
+4 10
.-
54 N
+4
*4
+1
*1
*4
*4
C-.59N00059’9N.’9
.
CC
C
+4 ICC
+4 40
C C
N C-
N
ItS
50
C
N
0)
N
14) C-
0 C.I
0 N
ICC
N
40 ‘9
N 0)
50 N
U) N
CO CL)
50 0
0
0
N
N
N
CO
Ii)
0
40
N
40
IL)
0
Ii)
0
N
N
N
40 C
0
C-
40
(5)
11 C N IONCCIOO)0040N
40
N C-
CCI C-
N
C
0
N
IL)
CO CCI
C
C
50
0
CC
C-i C-
N
N
C
N
*4
40 C-
4 4 C
N
+4 C C
N
4) 0 10000)59’90)’9
*1 Os
C N
4
+4 N
N N
#{149}
CCI
+4
CN
-
NC04NL004.-CCIN
r4
C a U
U
.40N4)NLa40OU)O
#{149} 11 CO
C
4 11
N 40
IL) N
.C
C
C
0
0
11 11 0 C
4 N. N
N 40
.-
N CCI
C
OQNC-4)CnC-N0)N
I
I
0
0
N
N
N
CD
‘0
N
CO
CC
IL) C0 NCCNCOON.NJCON)
N
II)
CO
40
CIi)
N
0)
0NCOC5)4)N
IL)
N
N
0
C
(5-
0 N N19’9’9C’9ONNO
OCO)NSOOU)CN
0
40
QCON.NLa40Q4050
CCLNU)NQ(5)NN.NN
C
CO C
ON10NNNONCCU)
NC
N
CO
N
N
N C-
C C
N N
0
N.
40 IL)
CO
N
-
40
40
40
N
C-
C
.-
I
I
ONN SOON
N
ON
N
C C
N
N. 0
US 50
0)
C-
IL)
C
0 C NCSOCC
N
C
0
50
N
N C
0
00
-
LU
IL) CC 05900NOCC)ONN
0
CO
IL)
C
.-
IL)
40
C
50
0)
.-
CCO 4.2*4
19400)
N N
0)
0 C N.
IL) N
2
N
CO
N
0
IS) CO
N U) 50
0.
0.
tC
U
1. CI
1. CI-
44 .40 C.)
20 .0 U
2.1 C #{149} U
44
.4-
C1.
C-C-N
C
04, O N.
N 0
N 10
40 CD 0)
IL) C 10
N 0)
#{149} CC
CD CC
C0 C-
0’ N .-
40
C4) N.
-
I
1. C
‘0 50
.0 C N S. QL
a,
N
I. C
N. 0) fl
(540
-
.40 C N
e
a
N S.
LU
0
1. C C N
-
1. .40 C N S. OS
U
1. .0 C N S. CC
-
IC
CC
S. .0 C N
50
0 N
-
.0 C CCI S. 95
t. C C N -
.0 C N S
a
UI E
S. .0 C N -
1. .40 C N
1. .40 C N
1!!!;
1I!1!;
=
44 U
>4 42 .0 CI
>4 21 VS
C0 4J
0 2-1 5)
>41.I.t1.1.1. 50 0
CO N C
44 C 0
‘0 C 0
41 C 0
II C 0
II C
‘0 C 0
0
4.2 .0 0)
II C 4CD
41
SC) ZCL)0
LO
..Jt0.
0 2-1 US
>4 0
4. C
U C
U C
U
=
41 C
U C
4-4-4-1.4-4-40 CD
CD
+4
CD
CD
Cl
05
CC
CC
U C U 0
N. N C
-
0.
CLUC
40W
000
>-0
ro.-
rIO-
November-December
0 4.1 VS
LU >
.
-
1978
535
SULLIVAN,
DL UHF,
WACKER,
ET
AL.
CLI
t
8
a
a a
8
a
‘iq.
1.
Daily
pressure, balance seven,
variations
hypertensive
thiazide
diuretics
and
JIfq2+
in
response
subsequent received
100
mg
to
a 100
fell
by 2.8
per
group
and
normal not
group change
day period cliuretirs also
cent
(P
2.3
per
(P